Inventor · disambiguated record
Daniel E. Lopes De Menezes
Also filed as: LOPES DE MENEZES DANIEL · LOPES DE MENEZES DANIEL E · LOPES DE MENEZES DANIEL ELVYN
1 granted patent·6 pending applications·0 citations·filing 2009–2025
14Inventor score
Top patents by PatentIndex Score
7 records- 0180US2025361313A1Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0277US2024228642A9Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0369US2021363267A1Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0464US11104739B2Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 31, 2021·0 cites·17 claims
- 0551US2010173873A1Treatment of metastasized tumorsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 0650US2024229156A1Methods for using a hypomethylating agent to treat diseases and disorders based on gene mutation profilesCELGENE CORP·Filed 2022·Application pending·0 cites
- 0738US2018179282A1Treatment of cancer by combined blockade of the pd-1 and cxcr4 signaling pathwaysBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel E. Lopes De Menezes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →